Thomas McCourt
Chief Executive OfficeratIronwood Pharmaceuticals· In proxies 2021–2025
Pay in FY2025-68% from the year before · Ironwood Pharmaceuticals stock -23.9% the same year
Thomas McCourt was paid $1.9M in FY2025 (Dec), down 68%. Ironwood Pharmaceuticals stock fell 23.9% that year.
Pay$100 in the stock at the end of FY20 → $32
Experience
- Ironwood PharmaceuticalsPublic company · 5 yr
- Chief Executive Officer2021 – Present · 5 yrStock in role -69%
- Pliant TherapeuticsPublic company · 2 yr
- Director2024 – Present · 2 yrNo stock prices for these years
- Acceleron Pharma Inc.Public company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
Two people shown as one, or a wrong number?